Article
Somatic Mutations and Outcomes in CML Adolescent and Young Adults Compared to Children, Adults, and BCR::ABL1-positive ALL Patients
2025-01-13
Abstract excerpt
<title>Abstract</title> <p>Adolescent and young adult (AYA) patients with chronic myeloid leukemia in chronic phase (CML-CP) reportedly fare worse on tyrosine kinase inhibitor (TKIs) than adults. This real-life study compared mutation profiles and outcomes in 80 AYA, 97 adult, and 16 pediatric CML-CP patients, alongside 81 <italic>BCR::ABL1</italic>-positive acute lymphoblastic leukemia (ALL) patients. Somatic mu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 12bae9e8-5651-501d-b326-8a49ffcf9713
- DOI
- 10.21203/rs.3.rs-5789724/v1